COVI-AgentSim: an Agent-based Model for Evaluating Methods of Digital Contact Tracing

The rapid global spread of COVID-19 has led to an unprecedented demand for effective methods to mitigate the spread of the disease, and various digital contact tracing (DCT) methods have emerged as a component of the solution. In order to make informed public health choices, there is a need for tools which allow evaluation and comparison of DCT methods. We introduce an agent-based compartmental simulator we call COVI-AgentSim, integrating detailed consideration of virology, disease progression, social contact networks, and mobility patterns, based on parameters derived from empirical research. We verify by comparing to real data that COVI-AgentSim is able to reproduce realistic COVID-19 spread dynamics, and perform a sensitivity analysis to verify that the relative performance of contact tracing methods are consistent across a range of settings. We use COVI-AgentSim to perform cost-benefit analyses comparing no DCT to: 1) standard binary contact tracing (BCT) that assigns binary recommendations based on binary test results; and 2) a rule-based method for feature-based contact tracing (FCT) that assigns a graded level of recommendation based on diverse individual features. We find all DCT methods consistently reduce the spread of the disease, and that the advantage of FCT over BCT is maintained over a wide range of adoption rates. Feature-based methods of contact tracing avert more disability-adjusted life years (DALYs) per socioeconomic cost (measured by productive hours lost). Our results suggest any DCT method can help save lives, support re-opening of economies, and prevent second-wave outbreaks, and that FCT methods are a promising direction for enriching BCT using self-reported symptoms, yielding earlier warning signals and a significantly reduced spread of the virus per socioeconomic cost.

[1]  Bjarne Stroustrup,et al.  C++ Programming Language , 1986, IEEE Softw..

[2]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.

[3]  E. Zagheni,et al.  Using time-use data to parameterize models for the spread of close-contact infectious diseases. , 2008, American journal of epidemiology.

[4]  Liliana Perez,et al.  An agent-based approach for modeling dynamics of contagious disease spread , 2009, International journal of health geographics.

[5]  Fred L. Drake,et al.  Python 3 Reference Manual , 2009 .

[6]  A. Badawi,et al.  Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey , 2013, Canadian Medical Association Journal.

[7]  Madhav V. Marathe,et al.  ISIS: a networked-epidemiology based pervasive web app for infectious disease pandemic planning and response , 2014, KDD.

[8]  Maire Sinha,et al.  Canadians' connections with family and friends , 2014 .

[9]  William Rand,et al.  An Introduction to Agent-Based Modeling: Modeling Natural, Social, and Engineered Complex Systems with NetLogo , 2015 .

[10]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[11]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[12]  Mark Jit,et al.  Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..

[13]  R. G. Ingalls,et al.  Agent-Based Modeling and Simulation , 2017, Encyclopedia of Machine Learning and Data Mining.

[14]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[15]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[16]  Hohyung Ryu,et al.  Agent-Based Modeling for Super-Spreading Events: A Case Study of MERS-CoV Transmission Dynamics in the Republic of Korea , 2018, International journal of environmental research and public health.

[17]  Haniye Sadat Sajadi,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[18]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[19]  Paul Lukowicz,et al.  grippeNET App: Enhancing Participatory Influenza Monitoring Through Mobile Phone Sensors , 2018, UbiComp/ISWC Adjunct.

[20]  Yamir Moreno,et al.  Projecting social contact matrices to different demographic structures , 2018, bioRxiv.

[21]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[22]  R. Hinch,et al.  Modeling the combined effect of digital exposure notification and non-pharmaceutical interventions on the COVID-19 epidemic in Washington state , 2020, medRxiv.

[23]  T. May Lockdown-type measures look effective against covid-19 , 2020, BMJ.

[24]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[25]  G. Gallacher,et al.  Remote Work and Employment Dynamics under COVID-19: Evidence from Canada , 2020, Canadian Public Policy. Analyse De Politiques.

[26]  M. S. Shamil,et al.  An Agent-Based Modeling of COVID-19: Validation, Analysis, and Recommendations , 2020, medRxiv.

[27]  A. Rossi,et al.  COVID-19 Pandemic and Lockdown Measures Impact on Mental Health Among the General Population in Italy , 2020, Frontiers in Psychiatry.

[28]  Lucie Abeler-Dörner,et al.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.

[29]  Dasheng Li,et al.  False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases , 2020, Korean journal of radiology.

[30]  Sanna Rimpiläinen Rapid Review of Contact Tracing Methods for COVID-19 , 2020 .

[31]  Leora I. Horwitz,et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.

[32]  Guanghai Wang,et al.  Mitigate the effects of home confinement on children during the COVID-19 outbreak , 2020, The Lancet.

[33]  Yiu Chung Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[34]  M. C. Nurchis,et al.  Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss , 2020, International journal of environmental research and public health.

[35]  Yoshua Bengio,et al.  COVI White Paper , 2020, ArXiv.

[36]  L. Luo,et al.  Modes of contact and risk of transmission in COVID-19 among close contacts , 2020, medRxiv.

[37]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[38]  Beau B. Bruce,et al.  Characteristics Associated with Hospitalization Among Patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[39]  M. Olfson,et al.  A stochastic agent-based model of the SARS-CoV-2 epidemic in France , 2020, Nature Medicine.

[40]  K. Rothman,et al.  Lockdown timing and efficacy in controlling COVID-19 using mobile phone tracking , 2020, EClinicalMedicine.

[41]  J. Knight,et al.  Estimating effective reproduction number using generation time versus serial interval, with application to covid-19 in the Greater Toronto Area, Canada , 2020, Infectious Disease Modelling.

[42]  A. Goyal,et al.  Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response , 2020, medRxiv.

[43]  Omar Yaxmehen Bello-Chavolla,et al.  Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico , 2020, The Journal of clinical endocrinology and metabolism.

[44]  A. L. Schmidt,et al.  Economic and social consequences of human mobility restrictions under COVID-19 , 2020, Proceedings of the National Academy of Sciences.

[45]  K. Bhaskaran,et al.  Factors associated with COVID-19-related death using OpenSAFELY , 2020, Nature.

[46]  R. Suman,et al.  Sustainability of Coronavirus on Different Surfaces , 2020, Journal of Clinical and Experimental Hepatology.

[47]  S. Zimmerman,et al.  The Need to Include Assisted Living in Responding to the COVID-19 Pandemic , 2020, Journal of the American Medical Directors Association.

[48]  G. Guglielmi,et al.  Fast coronavirus tests: what they can and can’t do , 2020, Nature.

[49]  A. Vespignani,et al.  Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19 , 2020, Nature Human Behaviour.

[50]  N. G. Davies,et al.  Age-dependent effects in the transmission and control of COVID-19 epidemics , 2020, Nature Medicine.

[51]  Vipin P. Veetil,et al.  The Economic Cost of COVID Lockdowns: An Out-of-Equilibrium Analysis , 2020, Economics of disasters and climate change.

[52]  Mark Briers,et al.  Risk scoring calculation for the current NHSx contact tracing app , 2020, ArXiv.

[53]  P. Klepac,et al.  Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project , 2020, medRxiv.

[54]  E. Robilotti,et al.  Determinants of COVID-19 disease severity in patients with cancer , 2020, Nature Medicine.

[55]  C. Fraser,et al.  Effective Configurations of a Digital Contact Tracing App: A report to NHSX , 2022 .